Pillstats
Rx only · Tablet, Film Coated, Extended Release · Oral

Tofacitinib

Brands: Xeljanz Xr · Tofacitinib Citrate

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1357536
US makers9 labelers
Packages16
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$59.76$119.52$179.29$239.05Jan 2026Jun 2026Jul 2026
$207.867
Latest avg · Jul 22, 2026
+0%
Since Jan 1, 2026
9
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.1K6.2K9.3K12K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.8K
Rx · 2026 Q1
316K
Units dispensed
-4%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Pharmaceuticals USA Inc.unknown4SUPPLYING
Zydus Lifesciences Limitedunknown4SUPPLYING
Pfizer Laboratories Div Pfizer Incunknown2SUPPLYING
Edenbridge Pharmaceuticals LLC.unknown1SUPPLYING
Apotex Corp.unknown1SUPPLYING
AvKAREunknown1SUPPLYING
Biocon Pharma Incunknown1SUPPLYING
Exelan Pharmaceuticals, Inc.unknown1SUPPLYING
Orient Pharma Co., Ltd. Yunlin Plantunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.